{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:06:07Z","timestamp":1789621567134,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jceh.2017.05.209","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T07:15:26Z","timestamp":1497597326000},"page":"42-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Increased Incidence of Post-transplant Lymphoproliferative Disorder in Autoimmune Liver Disease: An Irish National Experience"],"prefix":"10.1016","volume":"8","author":[{"given":"Ahmed","family":"Abu-Shanab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Ged","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diarmaid","family":"Houlihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiden","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jceh.2017.05.209_bib0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1053-2498(02)01229-9","article-title":"Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University","volume":"22","author":"Gao","year":"2003","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.jceh.2017.05.209_bib0245","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1053\/j.gastro.2009.08.070","article-title":"Long-term probability of and mortality from de novo malignancy after liver transplantation","volume":"137","author":"Watt","year":"2009","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jceh.2017.05.209_bib0250","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.23722","article-title":"Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection","volume":"19","author":"Schrem","year":"2013","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.jceh.2017.05.209_bib0255","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4254\/wjh.v8.i12.533","article-title":"Incidence, risk factors and outcomes of de novo malignancies post liver transplantation","volume":"8","author":"Mukthinuthalapati","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2017.05.209_bib0260","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"6","key":"10.1016\/j.jceh.2017.05.209_bib0265","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jceh.2017.05.209_bib0270","article-title":"Sequential treatment with Rituximab and CHOP chemotherapy in B-cell PTLD; moving forward to a first standard of care: results from a prospective international multicenter trial","author":"Trappe","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jceh.2017.05.209_bib0275","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1399-3062.2001.003002070.x","article-title":"Identifying the patient at risk for post-transplant lymphoproliferative disorder","volume":"3","author":"Cockfield","year":"2001","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"10.1016\/j.jceh.2017.05.209_bib0280","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients","volume":"71","author":"Tsai","year":"2001","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.jceh.2017.05.209_bib0285","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1600-6143.2008.02167.x","article-title":"Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids","volume":"8","author":"Tsai","year":"2008","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.jceh.2017.05.209_bib0290","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.jceh.2017.05.209_bib0295","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11912-010-0132-1","article-title":"Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy","volume":"12","author":"Evens","year":"2010","journal-title":"Curr Oncol Rep"},{"issue":"7","key":"10.1016\/j.jceh.2017.05.209_bib0300","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00535-010-0199-3","article-title":"Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases","volume":"45","author":"Koyabu","year":"2010","journal-title":"J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jceh.2017.05.209_bib0305","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1872-034X.2007.00284.x","article-title":"Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis","volume":"38","author":"Sakaki","year":"2008","journal-title":"Hepatol Res"},{"issue":"5","key":"10.1016\/j.jceh.2017.05.209_bib0310","first-page":"988","article-title":"Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases","volume":"23","author":"Martins","year":"1996","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jceh.2017.05.209_bib0315","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/gast.2001.22441","article-title":"The lymphoid liver: considerations on pathways to autoimmune injury","volume":"120","author":"Kita","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2017.05.209_bib0320","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1196\/annals.1422.059","article-title":"Epstein\"Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report","volume":"1108","author":"Barzilai","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.jceh.2017.05.209_bib0325","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2141.2010.08160.x","article-title":"Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society","volume":"149","author":"Parker","year":"2010","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.jceh.2017.05.209_bib0330","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.jceh.2017.05.209_bib0335","first-page":"1860","article-title":"Report of the Committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.jceh.2017.05.209_bib0340","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/00007890-199904150-00010","article-title":"Lymphoproliferative disorders after organ transplantation in children","volume":"67","author":"Dror","year":"1999","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jceh.2017.05.209_bib0345","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1046\/j.0007-1323.2001.01924.x","article-title":"Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients","volume":"88","author":"Libertiny","year":"2001","journal-title":"Br J Surg"},{"issue":"8886\"8887","key":"10.1016\/j.jceh.2017.05.209_bib0350","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz","year":"1993","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jceh.2017.05.209_bib0355","first-page":"2383","article-title":"Post-transplant lymphoproliferative disorders in liver transplanted patients: a single-centre experience","volume":"30","author":"Marino","year":"2010","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.jceh.2017.05.209_bib0360","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2012.43.2344","article-title":"Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score","volume":"31","author":"Caillard","year":"2013","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.jceh.2017.05.209_bib0365","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2008.20.0857","article-title":"Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center","volume":"27","author":"Knight","year":"2009","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jceh.2017.05.209_bib0370","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1155\/2015\/517359","article-title":"Post-transplant lymphoproliferative disorder in liver recipients: characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations","volume":"29","author":"Mumtaz","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jceh.2017.05.209_bib0375","first-page":"1127","article-title":"Primary sclerosing cholangitis and Hodgkin's disease","volume":"18","author":"Man","year":"1993","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jceh.2017.05.209_bib0380","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1155\/2012\/426430","article-title":"Management of primary sclerosing cholangitis: conventions and controversies","volume":"26","author":"Chandok","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jceh.2017.05.209_bib0385","article-title":"Autoimmune hepatitis following Epstein\"Barr virus infection","volume":"2008","author":"Cabibi","year":"2008","journal-title":"BMJ Case Rep"},{"issue":"12 suppl","key":"10.1016\/j.jceh.2017.05.209_bib0390","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1681\/ASN.V212s290","article-title":"Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression","volume":"2","author":"Melosky","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jceh.2017.05.209_bib0395","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2003","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.jceh.2017.05.209_bib0400","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/j.1600-6143.2005.01125.x","article-title":"Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil","volume":"5","author":"Robson","year":"2005","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.jceh.2017.05.209_bib0405","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.autrev.2006.02.006","article-title":"B cells and autoimmune liver diseases","volume":"5","author":"Moritoki","year":"2006","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.jceh.2017.05.209_bib0410","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/BF01296138","article-title":"Lymphocyte subsets in primary sclerosing cholangitis","volume":"32","author":"Lindor","year":"1987","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.jceh.2017.05.209_bib0415","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/hep.27313","article-title":"Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis","volume":"60","author":"Zhang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2017.05.209_bib0420","doi-asserted-by":"crossref","first-page":"987471","DOI":"10.1155\/2012\/987471","article-title":"Epstein-barr virus as a trigger of autoimmune liver diseases","volume":"2012","author":"Rigopoulou","year":"2012","journal-title":"Adv Virol"},{"issue":"8975","key":"10.1016\/j.jceh.2017.05.209_bib0425","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(95)91438-2","article-title":"Epstein\"Barr virus as a trigger for autoimmune hepatitis in susceptible individuals","volume":"346","author":"Vento","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jceh.2017.05.209_bib0430","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00042737-200402000-00017","article-title":"Fatal chronic active Epstein\"Barr virus infection mimicking autoimmune hepatitis","volume":"16","author":"Chiba","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jceh.2017.05.209_bib0435","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/BF02806528","article-title":"Increased expression of Epstein\"Barr virus in primary biliary cirrhosis patients","volume":"27","author":"Morshed","year":"1992","journal-title":"Gastroenterol Jpn"},{"key":"10.1016\/j.jceh.2017.05.209_bib0440","first-page":"189096","article-title":"CD8+ T-cell deficiency, Epstein\"Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis","volume":"2012","author":"Pender","year":"2012","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.jceh.2017.05.209_bib0445","first-page":"1","article-title":"Autoimmunity and environment: am I at risk?","author":"Smyk","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.jceh.2017.05.209_bib0450","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-4933-8-12","article-title":"Immunopathogenesis of primary biliary cirrhosis: an old wives tale","volume":"8","author":"Smyk","year":"2011","journal-title":"Immun Ageing"},{"issue":"6","key":"10.1016\/j.jceh.2017.05.209_bib0455","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1572-0241.1999.01148.x","article-title":"Epstein\"Barr virus infection of the colon with inflammatory bowel disease","volume":"94","author":"Yanai","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jceh.2017.05.209_bib0460","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cgh.2007.02.003","article-title":"Epstein\"Barr virus-associated lymphoma developed shortly after immunosuppressive treatment for ulcerative colitis","volume":"5","author":"Akamatsu","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.jceh.2017.05.209_bib0465","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/lt.21475","article-title":"Risk of malignant neoplasms after liver transplantation: a population-based study","volume":"14","author":"Aberg","year":"2008","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.jceh.2017.05.209_bib0470","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1600-6143.2007.01736.x","article-title":"Cancer incidence among Canadian kidney transplant recipients","volume":"7","author":"Villeneuve","year":"2007","journal-title":"Am J Transplant"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688317303791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688317303791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:04:06Z","timestamp":1760853846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688317303791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0973688317303791"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2017.05.209","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Incidence of Post-transplant Lymphoproliferative Disorder in Autoimmune Liver Disease: An Irish National Experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2017.05.209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 INASL.","name":"copyright","label":"Copyright"}]}}